GilOn Collaborates with Professors Kim Nayoung and Lee Youngjoo on 'AI Solution Based on Gait Analysis'

GilOn, a specialized company in digital healthcare solutions, announced on the 3rd that it is conducting joint research on an "AI solution for disease classification and treatment effect verification based on gait analysis" with Professor Kim Nayoung of the Department of Rehabilitation Medicine at Yongin Severance Hospital and Professor Lee Youngjoo of the Department of Electronic and Electrical Engineering at POSTECH.

GilOn and the research teams of Professors Kim Nayoung and Lee Youngjoo have been conducting related joint research since 2021. The study focuses on comparing the gait of patients with degenerative brain diseases and joint disorders that affect walking to that of normal elderly patients, distinguishing diseases causing gait disorders based on characteristic patterns. They are also researching an AI solution to verify improvements in gait following medical treatments such as medication or surgical interventions.

Recently, significant results have been derived from the research, and they are currently preparing a paper to publish in an academic journal.

Professor Kim Nayoung of Yongin Severance Hospital stated, “In elderly patients, gait disorders can be caused by various factors such as musculoskeletal diseases and degenerative brain diseases, but it is often difficult to differentiate the causes due to physical changes associated with normal aging. We expect that utilizing digital healthcare solutions will assist in diagnosis and evaluation of treatment effects.”

Professor Lee Youngjoo of POSTECH explained, “The development of AI solutions can enhance the accuracy and usability of digital healthcare products used in clinical settings.”

GilOn is considering applying the research results to commercial smart insoles and aims for a possible launch in 2024. Based on the research findings, they plan to introduce diagnostic support solutions (medical devices) that predict disease status through gait analysis and apply them to personal smart insoles called ‘ISOL,’ enabling users to predict disease signs in daily life and promptly visit medical facilities for early diagnosis support.

Kim Namsun, CEO of GilOn, said, “We are pleased to have conducted long-term joint collaboration with renowned domestic experts Professor Kim Nayoung and Professor Lee Youngjoo and to have achieved meaningful results. We will actively cooperate in developing various solutions in the medical and healthcare fields to contribute to maintaining healthy lives in the era of super-aging.”

This content was produced with the assistance of AI translation services.